Search results
Results from the WOW.Com Content Network
He is a graduate of Columbia University’s medical school, and obtained psychiatry residency training within the Icahn School of Medicine at Mount Sinai and child-adolescent psychiatry fellowship ...
Dennis S. Charney is an American biological psychiatrist and researcher, with expertise in the neurobiology and treatment of mood and anxiety disorders. [1] He is the author of Neurobiology of Mental Illness, The Physician's Guide to Depression and Bipolar Disorders and Molecular Biology for the Clinician, as well as the author of over 600 original papers and chapters.
Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]
As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy.
Feifel, a professor emeritus of psychiatry at the University of California, San Diego’s School of Medicine, was one of the first doctors to use ketamine off-label to treat depression at the ...
The New York Eye and Ear Infirmary of Mount Sinai is ranked #14 in ophthalmology. [49] Mount Sinai was ranked 8th among medical schools in the U.S. receiving NIH grants in 2022, [50] and 2nd in research dollars per principal investigator among U.S. medical schools by the Association of American Medical Colleges (AAMC). [51]
At Field Trip, a national chain of clinics that has offered ketamine-assisted psychotherapy for several mental health conditions since 2019, patients first undergo a screening to see if they ...
Reid Robison (born September 1976 in Illinois) is an American board-certified psychiatrist known primarily for his work with psychedelic medicines.As an early adopter and researcher of the use of ketamine in psychiatry, Robison has made significant contributions to ketamine-assisted psychotherapy (KAP) and other treatment modalities using ketamine for mental health conditions.